BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19751454)

  • 21. Initiating insulin in primary care--the role of modern premixed formulations.
    Ligthelm R; Davidson J
    Prim Care Diabetes; 2008 Feb; 2(1):9-16. PubMed ID: 18684415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensification of Gla-100 with Prandial Insulin: A Stepwise Progression Toward Glycemic Control.
    Wangnoo SK; Damodharan S; Sastry NG; Bhattacharyya S; Selvan C; Mohan B; Sarmah C; Arivazhahan A; Mohan V
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):43-48. PubMed ID: 33247663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?
    Raccah D; Bretzel RG; Owens D; Riddle M
    Diabetes Metab Res Rev; 2007 May; 23(4):257-64. PubMed ID: 17315242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telemedicine and diabetes: achievements and prospects.
    Franc S; Daoudi A; Mounier S; Boucherie B; Dardari D; Laroye H; Neraud B; Requeda E; Canipel L; Charpentier G
    Diabetes Metab; 2011 Dec; 37(6):463-76. PubMed ID: 21889388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating the whole patient for optimal management of type 2 diabetes: considerations for insulin therapy.
    Campos C
    South Med J; 2007 Aug; 100(8):804-11. PubMed ID: 17713307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indian insulin guidelines: a year later and the road ahead.
    Moses A
    J Assoc Physicians India; 2011 Apr; 59 Suppl():23-4. PubMed ID: 21823252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fast-acting insulin - new developments towards more flexibility for the patient].
    Schmeisl GW; Kretzschmar Y
    MMW Fortschr Med; 2016 Dec; 158(Suppl 6):5-11. PubMed ID: 27933575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus evidence-based guidelines for insulin initiation, optimization and continuation in type 2 diabetes mellitus.
    Shah S; Sharma SK; Singh P; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):49-54. PubMed ID: 25668937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What next after basal insulin? Treatment intensification with lixisenatide in Asian patients with type 2 diabetes mellitus.
    Chan WB; Luk A; Chow WS; Yeung VTF
    J Diabetes; 2017 Jun; 9(6):562-574. PubMed ID: 27976513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the role of basal and prandial insulin for optimal glycemic control.
    Horton ES
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S21-7. PubMed ID: 19179213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal Glucose Can Be Controlled, but the Prandial Problem Persists-It's the Next Target!
    Riddle MC
    Diabetes Care; 2017 Mar; 40(3):291-300. PubMed ID: 28223444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Premixed insulin and intermediate-acting insulin].
    Morishita H
    Nihon Rinsho; 2015 Mar; 73(3):453-7. PubMed ID: 25812372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitus.
    Hirsch IB; Schneider D; King A; Polonsky WH; Reid TS; Shubrook J; Verderese CA; Wallace J; Riddle MC
    Postgrad Med; 2014 May; 126(3):135-44. PubMed ID: 24918799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Basal insulins.
    Mora PF
    J Fam Pract; 2017 Oct; 66(10 Suppl):S7-S11. PubMed ID: 28991931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
    Ghosh S; Unnikrishnan AG; Saboo B; Kesavadev J; Aravind SR; Bajaj S; Rajput R; Seshadri K; Verma N; Gupta A; Makkar BM; Saikia M; Kale S; Damodaran S; Dengra A; Eashwar TKM; Maheshwari A; Pendsey S; Phatak SR; Sharma SK; Singh SK; Ramachandran A; Zargar AH; Joshi SR; Sadikot SM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S507-S521. PubMed ID: 28433618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensification lessons with modern premixes: from clinical trial to clinical practice.
    Guler S; Vaz JA; Ligthelm R
    Diabetes Res Clin Pract; 2008 Sep; 81 Suppl 1():S23-30. PubMed ID: 18684540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The when and how of insulin initiation in type 2 diabetes.
    Liebl A
    Curr Med Res Opin; 2007 Jan; 23(1):129-32. PubMed ID: 17257474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy of insulin intensification after basal failure for type 2 diabetes in the outpatient setting.
    Tarigan TJ; Utami Y
    Acta Med Indones; 2011 Apr; 43(2):144-7. PubMed ID: 21785179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin for type 2 diabetes: choosing a second-line insulin regimen.
    Barnett A; Begg A; Dyson P; Feher M; Hamilton S; Munro N
    Int J Clin Pract; 2008 Nov; 62(11):1647-53. PubMed ID: 19143853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gluco-phenotype.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2016 Jan; 66(1):118-9. PubMed ID: 26712197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.